Replies to post #10754 on GTC Biotherapeutics (fka GTCB)

[julescat]

Baxter - that was my guess on partner a while back and that
Cox comment is certainly not inconsistent with that possibility. I'm still thinking BAX.

[DewDiligence]

BAX could well have been the partner who pulled out. (‘alia’ joked about this in #msg-29137897.) However, if BAX was in fact the one, I doubt that the heparin problem was their main reason to walk away from an almost-signed ATryn deal.